1. Medtech Insight

Abbott Launches Trial Of DBS Depression Treatment

 
• By Elizabeth Orr

The DBS trial will look at the use of neurostimulation in people with treatment-resistant depression, which affects about 2.8 million Americans each year. The implanted device may relieve depression symptoms by changing activity patterns in the brain.

Drawing of a woman standing under a raincloud and looking toward sunshine.
• Source: Shutterstock

Abbott is launching a pivotal trial of its Deep Brain Stimulation (DBS) device in people with treatment-resistant depression, the company announced on 4 September.

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Medtech Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Clinical Trials

More from R&D